The pathogenesis of Hodgkin's disease

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Extensive clinical research over the past few decades has changed Hodgkin's disease from a routinely fatal disease to a usually curable disease. However, treatment is far from perfect; a substantial percentage of patients are not cured of their primary disease, and a substantial percentage of patients die of treatment-related second malignancies. Present efforts in clinical research are likely to result in improved antitumor therapy and a reduction in second malignancies; however, it is unrealistic to expect that they will result in striking improvements. Major new advances in Hodgkin's disease will require a better understanding of the biology of the disease.

Original languageEnglish (US)
Pages (from-to)61-68
Number of pages8
JournalBlood Reviews
Volume4
Issue number1
DOIs
StatePublished - 1990

Fingerprint

Hodgkin Disease
Second Primary Neoplasms
Research
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

The pathogenesis of Hodgkin's disease. / Collins, R. H.

In: Blood Reviews, Vol. 4, No. 1, 1990, p. 61-68.

Research output: Contribution to journalArticle

Collins, R. H. / The pathogenesis of Hodgkin's disease. In: Blood Reviews. 1990 ; Vol. 4, No. 1. pp. 61-68.
@article{3562288d1c8341768ec4961b183a94ee,
title = "The pathogenesis of Hodgkin's disease",
abstract = "Extensive clinical research over the past few decades has changed Hodgkin's disease from a routinely fatal disease to a usually curable disease. However, treatment is far from perfect; a substantial percentage of patients are not cured of their primary disease, and a substantial percentage of patients die of treatment-related second malignancies. Present efforts in clinical research are likely to result in improved antitumor therapy and a reduction in second malignancies; however, it is unrealistic to expect that they will result in striking improvements. Major new advances in Hodgkin's disease will require a better understanding of the biology of the disease.",
author = "Collins, {R. H.}",
year = "1990",
doi = "10.1016/0268-960X(90)90016-L",
language = "English (US)",
volume = "4",
pages = "61--68",
journal = "Blood Reviews",
issn = "0268-960X",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - The pathogenesis of Hodgkin's disease

AU - Collins, R. H.

PY - 1990

Y1 - 1990

N2 - Extensive clinical research over the past few decades has changed Hodgkin's disease from a routinely fatal disease to a usually curable disease. However, treatment is far from perfect; a substantial percentage of patients are not cured of their primary disease, and a substantial percentage of patients die of treatment-related second malignancies. Present efforts in clinical research are likely to result in improved antitumor therapy and a reduction in second malignancies; however, it is unrealistic to expect that they will result in striking improvements. Major new advances in Hodgkin's disease will require a better understanding of the biology of the disease.

AB - Extensive clinical research over the past few decades has changed Hodgkin's disease from a routinely fatal disease to a usually curable disease. However, treatment is far from perfect; a substantial percentage of patients are not cured of their primary disease, and a substantial percentage of patients die of treatment-related second malignancies. Present efforts in clinical research are likely to result in improved antitumor therapy and a reduction in second malignancies; however, it is unrealistic to expect that they will result in striking improvements. Major new advances in Hodgkin's disease will require a better understanding of the biology of the disease.

UR - http://www.scopus.com/inward/record.url?scp=0025312197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025312197&partnerID=8YFLogxK

U2 - 10.1016/0268-960X(90)90016-L

DO - 10.1016/0268-960X(90)90016-L

M3 - Article

VL - 4

SP - 61

EP - 68

JO - Blood Reviews

JF - Blood Reviews

SN - 0268-960X

IS - 1

ER -